Femasys Inc (FEMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FEMY | AZN | AMGN | GILD | VRTX |
| Company | Femasys Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.6813 | 92.33 | 332.46 | 124.82 | 463.00 |
| High | 0.6813 | 92.89 | 333.50 | 125.27 | 463.55 |
| Low | 0.5395 | 92.33 | 329.47 | 124.20 | 457.45 |
| Latest | 0.6047 | 92.52 | 329.63 | 124.91 | 459.78 |
| Change | -0.1054 | -0.38 | -3.30 | +0.21 | -3.12 |
| % Change | -14.84% | -0.41% | -0.99% | +0.17% | -0.67% |
| Volume | 4,824,119 | 2,288,490 | 1,905,456 | 3,000,285 | 627,792 |
| 20-Day Average Volume | 1,542,918 | 5,291,662 | 3,016,177 | 6,863,357 | 1,355,474 |
| Previous Close | 0.7101 | 92.90 | 332.93 | 124.70 | 462.90 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8234 | 91.05 | 328.35 | 122.63 | 451.23 |
| 20-Day Raw Stochastic | 17.08% | 90.18% | 53.14% | 69.26% | 86.96% |
| 20-Day Relative Strength | 39.87 | 60.68 | 54.51 | 54.17 | 59.44 |
| Weighted Alpha | -72.66 | +42.68 | +26.20 | +33.02 | +13.06 |
| Today's Opinion | 40% Sell | 100% Buy | 96% Buy | 80% Buy | 72% Buy |
| Previous Opinion | 24% Sell | 100% Buy | 96% Buy | 80% Buy | 72% Buy |
| Last Month's Opinion | 24% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -28.34% since 12/19/25 | +1.49% since 12/19/25 | +0.94% since 12/19/25 | +0.23% since 12/19/25 | +0.63% since 12/19/25 |
| Low | 0.5403 on 12/29/25 | 90.63 on 12/22/25 | 326.08 on 12/22/25 | 122.84 on 12/22/25 | 453.03 on 12/22/25 |
| High | 0.8662 on 12/22/25 | 93.10 on 12/23/25 | 334.38 on 12/24/25 | 127.41 on 12/23/25 | 464.44 on 12/24/25 |
| 1-Month | |||||
| %Chg | -38.90% since 11/28/25 | +0.01% since 11/28/25 | -4.34% since 11/28/25 | -1.01% since 11/28/25 | +5.88% since 11/28/25 |
| Low | 0.5403 on 12/29/25 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 423.45 on 12/01/25 |
| High | 0.9900 on 12/01/25 | 93.10 on 12/23/25 | 346.38 on 12/03/25 | 127.41 on 12/23/25 | 464.44 on 12/24/25 |
| 3-Month | |||||
| %Chg | +75.31% since 09/29/25 | +25.08% since 09/29/25 | +20.62% since 09/29/25 | +10.61% since 09/29/25 | +16.14% since 09/29/25 |
| Low | 0.3420 on 09/30/25 | 73.96 on 09/30/25 | 274.02 on 09/30/25 | 108.46 on 10/02/25 | 385.86 on 09/30/25 |
| High | 1.1100 on 11/11/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 464.44 on 12/24/25 |
| 6-Month | |||||
| %Chg | -37.03% since 06/27/25 | +32.75% since 06/27/25 | +19.24% since 06/27/25 | +12.56% since 06/27/25 | +4.03% since 06/27/25 |
| Low | 0.3067 on 08/26/25 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 362.50 on 08/11/25 |
| High | 1.1100 on 11/11/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 41,527 | 288,124,864 | 179,276,480 | 154,712,800 | 117,446,520 |
| Shares Outstanding, K | 58,480 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 1,630,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -18,820,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 730,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -4,190,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | -2.59 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 11/14/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/26/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.23 | 15.27 | 15.34 | 30.24 |